业务分离

Search documents
Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
Seeking Alpha· 2025-06-09 20:48
Becton, Dickinson and Company (NYSE:BDX) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 2:00 PM ET Company Participants Thomas E. Polen - President, CEO & Chairman Conference Call Participants Robert Justin Marcus - JPMorgan Chase & Co, Research Division Unidentified Analyst Yes. One additional disclosure that we needed. So the session is not open to the press. There you go. All right. So I want to thank Tom Polen, Chairman and Chief Executive Officer of Becton, Dickinson. I appreciate ...
三星,或拆分晶圆厂
半导体行业观察· 2025-05-23 01:21
如果您希望可以时常见面,欢迎标星收藏哦~ 来源:内容编译自businesskorea 。 继三星生物制剂公司于5月22日宣布将其合同开发与制造(CDMO)业务与生物仿制药业务完全分 离之后,三星电子半导体部门内部晶圆代工业务分离的可能性再次浮现。此举源于客户公司对利益 冲突的持续担忧,因为三星的半导体部门也同时在"同一屋檐下"运营设计和生产。一些分析师认 为,分离晶圆代工业务可能是摆脱长期亏损困境的突破口。 据业内人士5月22日透露,导致三星生物制剂业务剥离的利益冲突问题,也令负责三星半导体业务 的设备解决方案(DS)部门感到担忧。三星晶圆代工厂采用3纳米(纳米,十亿分之一米)尖端工 艺制造半导体,并计划在年内实现2纳米工艺的量产。尽管三星晶圆代工厂规模不及全球最大晶圆 代工厂台积电,但作为全球晶圆代工行业第二大企业,三星晶圆代工厂仍拥有相当大的竞争优势, 然而,其在争取订单方面却一直举步维艰。 虽然三星代工的技术能力和产量问题是造成这一问题的因素,但业内分析师主要将问题归咎于利益 冲突。由于 DS 部门还设有负责半导体设计的系统 LSI,因此苹果、Nvidia 和高通等专门从事设 计的大型科技公司担心,如果 ...
Fortive(FTV) - 2025 Q1 - Earnings Call Transcript
2025-05-01 16:00
Financial Data and Key Metrics Changes - Fortive reported adjusted earnings per share of $0.85, which is in line with expectations, reflecting a 2% year-over-year growth [5][14] - Core revenue declined by 2% year-over-year, slightly below expectations, with total revenue down 3% due to foreign exchange headwinds [13][14] - Adjusted operating profit was $373 million, with adjusted operating margin expansion of 20 basis points [14] - Adjusted free cash flow was better than expected at $222 million, with a 7% increase in six-month growth [14][27] Business Line Data and Key Metrics Changes - Intelligent Operating Solutions (IOS) segment grew core revenues by 2%, while Advanced Healthcare Solutions (AHS) grew by 2.5% [16][18] - Precision Technologies (PT) segment experienced an 8.4% core revenue decline, driven by lower orders in Test and Measurement and shipment delays in Sensors and Safety Systems [13][20] - IOS segment adjusted operating margins expanded by 150 basis points, while AHS saw a 70 basis point contraction in adjusted operating margins [17][19] Market Data and Key Metrics Changes - North America showed stable industrial demand, while Europe and China faced a more challenging macro environment [16] - The company expects China to be down high single digits for the year, reflecting increased challenges [126] - Overall, North America is anticipated to remain the strongest market for Fortive [125] Company Strategy and Development Direction - Fortive is focusing on enhancing supply chain resilience, having reduced exposure to imports from China by 70% since 2018 [7][23] - The company is targeting the completion of its separation by the end of the second quarter, which is expected to unlock shareholder value [30][32] - Fortive aims to increase its recurring revenue mix from approximately 40% to roughly 50% post-separation [30] Management's Comments on Operating Environment and Future Outlook - Management acknowledged a more dynamic macro environment and moderating demand in PT, with expectations for a modest improvement in the segment [7][28] - The company is implementing countermeasures to mitigate tariff impacts, estimating a gross tariff impact of $190 million to $220 million [24][27] - Management remains confident in the ability to navigate current challenges and deliver best-in-class net working capital performance [27][30] Other Important Information - The company announced the appointment of a new CFO, Mark Okerstrom, who is expected to drive additional shareholder value [8][10] - Fortive's strategic approach includes pricing adjustments and optimizing sourcing and logistics to mitigate tariff impacts [25][26] Q&A Session Summary Question: Clarification on localizing production - Management indicated that localizing production involves accelerating existing plans rather than building new capacity in the U.S. [41][42] Question: Insights on Test and Measurement decline - The decline was attributed to customers delaying orders due to increased policy and macro uncertainty, with expectations for recovery pushed to 2026 [44][46] Question: Volatility in Test and Measurement industry - The volatility is linked to the sector's exposure to R&D investments, which customers can delay amid economic uncertainty [53][55] Question: Clarification on tariff impacts - Management clarified that the estimated tariff impact for 2025 is around $200 million, with plans to offset about 80% of it [82][90] Question: Expectations for North America and Western Europe - North America is expected to perform well, while China is anticipated to face challenges, with a projected decline in revenue [125][126]
Honeywell(HON) - 2025 Q1 - Earnings Call Transcript
2025-04-29 18:20
Honeywell (HON) Q1 2025 Earnings Call April 29, 2025 02:20 PM ET Speaker0 Thank you for standing by, and welcome to the Honeywell First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's call is being recorded. I would now like to hand the call over to Sean Meakim, Vice President of Investor Relations. Please go ahead. Speaker1 Thank you. G ...